Finance

Beta
Lists
PMI:NYSEAMERICAN
Picard Medical Inc
$0.15
-1.67%
(-0.0025) 1D
$0.14
-2.78% (-0.0041)
After hours
Closed: May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMI...
Open
$0.16
High
$0.16
Low
$0.14
Mkt. cap
13.62M
Avg. vol.
15.85M
Volume
16.61M
52-wk high
$13.68
52-wk low
$0.11
EPS
-$0.41
Shares outstanding
92.35M
No. of employees
75
Open
$0.16
High
$0.16
Low
$0.14
Mkt. cap
13.62M
Avg. vol.
15.85M
Volume
16.61M
52-wk high
$13.68
52-wk low
$0.11
EPS
-$0.41
Shares outstanding
92.35M
No. of employees
75
News stories
From sources across the web
About Picard Medical Inc
CEO-
Employees75
Founded2021
HeadquartersTucson, Arizona, United States
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.12M
1.19M
1.01M
1.15M
Cost of goods sold
2.25M
1.32M
598.00K
875.00K
Cost of revenue
2.25M
1.32M
598.00K
875.00K
Research and development expenses
743.00K
951.00K
547.00K
1.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.65M
2.41M
2.87M
2.89M
Operating expense
3.39M
3.36M
3.41M
4.79M
Total operating expenses
5.64M
4.67M
4.01M
5.66M
Operating income
-3.52M
-3.49M
-3.00M
-4.51M
Other non operating income
-776.00K
-4.54M
-2.29M
-
EBT including unusual items
-6.72M
-10.43M
-4.29M
-7.62M
EBT excluding unusual items
-6.72M
-10.43M
-5.30M
-4.52M
Income tax expense
-
-
4.00K
-
Effective tax rate
-
-
-0.09%
-
Other operating expenses
-
-
-
-
Net income
-6.72M
-10.43M
-4.29M
-7.62M
Net profit margin
-316.57%
-878.35%
-425.27%
-662.26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.43M
-2.40M
-7.00K
-5.00K
Net interest expenses
-2.43M
-2.40M
-7.00K
-5.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.48M
-3.45M
-2.96M
-4.46M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more